Acadia Healthcare (NASDAQ:ACHC) Raised to Overweight at KeyCorp

Acadia Healthcare (NASDAQ:ACHC) was upgraded by equities research analysts at KeyCorp from a “sector weight” rating to an “overweight” rating in a research note issued to investors on Tuesday, Marketbeat reports. The firm presently has a $70.00 price target on the stock. KeyCorp’s target price indicates a potential upside of 55.14% from the company’s current price. KeyCorp also issued estimates for Acadia Healthcare’s Q2 2025 earnings at $0.85 EPS and Q3 2025 earnings at $0.92 EPS.

Several other research analysts also recently issued reports on the company. Cantor Fitzgerald reaffirmed a “neutral” rating and set a $52.00 price objective on shares of Acadia Healthcare in a report on Tuesday, December 10th. Royal Bank of Canada reduced their price objective on Acadia Healthcare from $94.00 to $64.00 and set an “outperform” rating on the stock in a report on Monday, November 18th. StockNews.com downgraded Acadia Healthcare from a “hold” rating to a “sell” rating in a report on Monday. Barclays cut their price target on Acadia Healthcare from $76.00 to $43.00 and set an “overweight” rating on the stock in a research note on Friday, November 22nd. Finally, Deutsche Bank Aktiengesellschaft raised Acadia Healthcare from a “hold” rating to a “buy” rating and increased their price target for the company from $45.00 to $75.00 in a research note on Thursday, December 12th. One analyst has rated the stock with a sell rating, two have assigned a hold rating and seven have given a buy rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $70.22.

Acadia Healthcare Stock Down 0.0 %

Shares of ACHC opened at $45.12 on Tuesday. The company has a market capitalization of $4.19 billion, a P/E ratio of 14.79, a PEG ratio of 1.77 and a beta of 1.29. The company has a debt-to-equity ratio of 0.60, a current ratio of 1.07 and a quick ratio of 1.07. Acadia Healthcare has a one year low of $36.50 and a one year high of $87.77. The business’s 50 day simple moving average is $40.43 and its 200-day simple moving average is $58.28.

Acadia Healthcare (NASDAQ:ACHC) last posted its quarterly earnings data on Wednesday, October 30th. The company reported $0.91 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.90 by $0.01. Acadia Healthcare had a return on equity of 11.12% and a net margin of 8.99%. The firm had revenue of $815.60 million for the quarter, compared to the consensus estimate of $819.42 million. During the same quarter in the prior year, the business earned $0.91 EPS. The business’s revenue for the quarter was up 8.7% compared to the same quarter last year. As a group, sell-side analysts predict that Acadia Healthcare will post 3.38 EPS for the current fiscal year.

Institutional Trading of Acadia Healthcare

Large investors have recently made changes to their positions in the company. GAMMA Investing LLC increased its position in shares of Acadia Healthcare by 57.1% in the 3rd quarter. GAMMA Investing LLC now owns 663 shares of the company’s stock valued at $42,000 after buying an additional 241 shares in the last quarter. Point72 Asia Singapore Pte. Ltd. bought a new stake in shares of Acadia Healthcare in the 2nd quarter valued at $59,000. Covestor Ltd increased its position in shares of Acadia Healthcare by 834.4% in the 3rd quarter. Covestor Ltd now owns 1,140 shares of the company’s stock valued at $72,000 after buying an additional 1,018 shares in the last quarter. DekaBank Deutsche Girozentrale bought a new stake in shares of Acadia Healthcare in the 3rd quarter valued at $86,000. Finally, Assetmark Inc. increased its position in shares of Acadia Healthcare by 66.1% in the 3rd quarter. Assetmark Inc. now owns 1,485 shares of the company’s stock valued at $94,000 after buying an additional 591 shares in the last quarter.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.